Ticker Details
Gossamer Bio, Inc.
IPO Date:	February 4, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$493M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 3.61%
Avg Daily Range (30 D):	$0.09 | 4.76%
Avg Daily Range (90 D):	$0.10 | 4.09%

Institutional Daily Volume
Avg Daily Volume:	1.56M
Avg Daily Volume (30 D):	15.54M
Avg Daily Volume (90 D):	7.4M

Trade Size
Avg Trade Size (Sh.):	214
Avg Trade Size (Sh.) (30 D):	548
Avg Trade Size (Sh.) (90 D):	367

Institutional Trades
Total Institutional Trades:	1,347
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$.8M
Avg Institutional Trade (90 D):	$1.27M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.7M
Avg Closing Trade (30 D):	$.87M
Avg Closing Trade (90 D):	$1.48M
Avg Closing Volume:	345.07K

News

Sep 25, 2025 @ 11:41 AM Respira Therapeutics Enters into Agreement with Go... Source: Prnewswire

Sep 25, 2025 @ 11:31 AM Gossamer Bio Enters into Option Agreement to Acqui... Source: Business Wire

Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight

Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight

Dec 2, 2024 @ 12:30 PM XOMA Royalty Acquires Pulmokine for $20 Million Ad... Source: Globe Newswire

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.69	$-.21	$-.17
Diluted EPS	$-.69	$-.21	$-.17
Revenue	$44.05M	$13.29M	$11.49M
Gross Profit
Net Income / Loss	$-156.16M	$-48.22M	$-38.27M
Operating Income / Loss	$-160.82M	$-49.11M	$-38.77M
Cost of Revenue
Net Cash Flow	$-19.55M	$-17.28M	$-2.84M
PE Ratio